An interventional study of Expiratory Muscle Strength Training Device (EMST 150) and Oropharyngeal Myofunctional Therapy (MT) in Obstructive Sleep Apnea, sponsored by University Hospitals Cleveland Medical Center. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-17.
Sponsored by University Hospitals Cleveland Medical Center · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 754 studies in Sleep Apnea, Obstructive with a site in United States — 127 open to participants now, 161 under way, 9 of them phase 3. Sleep Apnea, Obstructive · United States.
Among the 754 studies in Sleep Apnea, Obstructive with a site in United States, this one is the 447th largest by planned enrollment of the 595 interventional ones that give a count, is one of 42 that started in 2026, is one of 411 with no phase, reaches primary completion later than 115 of the 160 other live ones, and was the 754th registered.
2,243 studies on the registry are indexed under Sleep Apnea, Obstructive; 475 are open to participants now.
Browse Sleep Apnea, Obstructive studies →127 of the 754 studies in Sleep Apnea, Obstructive with a site in United States are open now. Recruiting first, the newest first:
Pfizer · Sites in United States
Ages 18+
Nevada Dental Sleep · Sites in United States
Ages 18+
University of Chicago · Sites in United States
Ages 18–40 · Women only
Fisher and Paykel Healthcare · Sites in United States
Ages 22+
Brigham and Women's Hospital · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 313 Sleep Apnea, Obstructive studies recruiting now, 146 (47%) set no upper age limit and 124 (40%) stop at 75 or younger; 52 take children under 18; 65 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
754 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 52 · Phase 2 85 · Phase 3 45 · Phase 4 36
First in 1999; this study’s year is marked. 42 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 52 across 1,474 interventional studies indexed under Sleep Apnea, Obstructive.
Median enrollment 49 across the 595 interventional studies, 81 across the 157 observational. Of the 512 that completed or were terminated, 257 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
192 of 754 have an industry lead sponsor. The 10 most frequent:
University Hospitals Cleveland Medical Center is the lead sponsor of 296 studies on the registry; 46 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 30 (83%) have results posted.
University Hospitals Cleveland Medical Center has 2 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
66 of the studies in Sleep Apnea, Obstructive with a site in United States that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07225686Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure Therapy | 2027-08-20 |
| NCT07226765Phase 3AmgenMaridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy | 2027-08-30 |
| NCT07613281Serene Sleep, Inc.Serene Sleep Palatal Implant System Clinical Confirmatory Trial in Participants Who Snore or Are Diagnosed With Mild-to-moderate Obstructive Sleep Apnea (OSA). | 2026-11 |
| NCT04814420Tulane UniversityAtrial Fibrosis in Obstructive Sleep Apnea Patients: A Pilot Study | 2026-11 |
| NCT07103941Isabel Moreno HayIOA Preventing Occlusal Changes With MAD Use | 2026-11-28 |
Add all 66 to your calendar (.ics) → With an account.
Among the 754 studies in Sleep Apnea, Obstructive with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Obstructive Sleep Apnea is a condition in which the upper airway repeatedly becomes blocked during sleep, often due to weakness or collapse of the upper airway throat muscles. The purpose of this study is to evaluate whether combining a handheld breathing device (Expiratory Muscle Strength Training (EMST 150)) with structured, speech-language pathology-Guided mouth and throat exercises can help strengthen the muscles that keep the airway open, reduce snoring, and reduce sleep apnea severity while improving overall sleep quality. Participation in this study will last about 3 months. This includes a 5-week home breathing exercise program, two in-person clinic visits (at the beginning of the study and at Month 3), and two short phone check-ins.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult participants diagnosed with mild-to-moderate obstructive OSA.
Device: Expiratory Muscle Strength Training Device (EMST 150) · Behavioral: Oropharyngeal Myofunctional Therapy (MT)
Participants utilize the EMST 150 device to strengthen expiratory and upper airway musculature. During training, participants inhale deeply and exhale forcefully through the mouthpiece again calibrated resistance while maintaining an airtight lip seal to overcome the target threshold pressure.
Participants perform structured oral motor exercises : * Lingual maneuvers * Soft palate and velopharyngeal exercises * Facial and buccinator muscle conditioning to reinforce nasal breathing.
Change in Sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI)
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire that evaluates overall sleep quality and disturbances over a one-month time interval. With higher scores indicating poor sleep quality.
Time frame: Baseline, 3 months
Change in Daytime sleepiness as measured by the Epworth Sleepiness Scale (ESS)
The Epworth Sleepiness Scale (ESS) is a short, self-administered questionnaire used to measure a person's general level of daytime sleepiness and likelihood of dozing off in everyday situations. Scored on a scale from 0 would never doze, to 3 high chance of dozing.
Time frame: Baseline, 3 months
Snore score as measured by smartphone application monitoring.
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics.
Time frame: Up to 3 months
Percentage of snoring sleep time as measured by smartphone application monitoring.
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics.
Time frame: Up to 3 months
Noise intensity in decibels as measured by smartphone application monitoring.
Smartphone application monitoring (Snorelab) will be used to track longitudinal acoustic changes in nightly snoring. The application analyzes breathing sounds to compute aggregate acoustic metrics.
Time frame: Up to 3 months
Change in Isometric maximal tongue pressure (kPa) as measured by the Iowa Oral Performance Instrument (IOPI)
The Iowa Oral Performance Instrument (IOPI) is a portable, evidence-based medical device used to objectively measure, document, and train lip and tongue strength and endurance. The device digitally records maximum isometric pressure in kilopascals
Time frame: Baseline, 3 months
Change in tongue muscle endurance as measured by time in seconds sustained at 50% maximal pressure.
Time in seconds sustained at 50% maximal pressure.
Time frame: Baseline, 3 months
Change in Apnea-Hypopnea Index (AHI)
The apnea-hypopnea index (AHI) is the average number of breathing pauses (apneas) and shallow breathing events (hypopneas) that occur per hour of sleep, with higher scores indicating greater sleep apnea severity.
Time frame: Baseline, 3 months
Change in Maximum Expiratory Pressure (MEP)
MEP is the highest positive pressure generated by a person during a forced exhalation against a blocked airway. It measures the strength of the expiratory muscles, including the abdominal and internal intercostal muscles, and helps evaluate cough efficiency and neuromuscular function. Lower scores indicate generalized respiratory muscle weakness, chronic obstructive pulmonary disease (COPD), or neuromuscular conditions like myasthenia gravis or Guillain-Barré syndrome.
Time frame: Baseline, 3 months
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.
Of 508 non-industry interventional studies with no phase under Sleep Apnea, Obstructive, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 53. This study's planned 12 months is below that.
Counting every sponsor, half of 624 studies reached it within 27 months; a quarter within 12 and three quarters within 50.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospitals Cleveland Medical Center →